vs
Side-by-side financial comparison of CPI AEROSTRUCTURES INC (CVU) and FENNEC PHARMACEUTICALS INC. (FENC). Click either name above to swap in a different company.
CPI AEROSTRUCTURES INC is the larger business by last-quarter revenue ($19.4M vs $13.8M, roughly 1.4× FENNEC PHARMACEUTICALS INC.). CPI AEROSTRUCTURES INC runs the higher net margin — 3.6% vs -34.7%, a 38.3% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs -10.8%). Over the past eight quarters, CPI AEROSTRUCTURES INC's revenue compounded faster (0.9% CAGR vs -26.3%).
CPI Aerostructures Inc., known as CPI Aero, is a contract aircraft component manufacturer based in Edgewood, New York.
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
CVU vs FENC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.4M | $13.8M |
| Net Profit | $691.8K | $-4.8M |
| Gross Margin | 20.3% | — |
| Operating Margin | 6.4% | -18.5% |
| Net Margin | 3.6% | -34.7% |
| Revenue YoY | -10.8% | 73.8% |
| Net Profit YoY | -28.8% | -141.1% |
| EPS (diluted) | $0.04 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.4M | $13.8M | ||
| Q3 25 | $19.3M | $12.5M | ||
| Q2 25 | $15.2M | $9.7M | ||
| Q1 25 | $15.4M | $8.8M | ||
| Q4 24 | $21.8M | $7.9M | ||
| Q3 24 | $19.4M | $7.0M | ||
| Q2 24 | $20.8M | $7.3M | ||
| Q1 24 | $19.1M | $25.4M |
| Q4 25 | $691.8K | $-4.8M | ||
| Q3 25 | $1.1M | $-638.0K | ||
| Q2 25 | $-1.3M | $-3.2M | ||
| Q1 25 | $-1.3M | $-1.2M | ||
| Q4 24 | $971.5K | $-2.0M | ||
| Q3 24 | $749.7K | $-5.7M | ||
| Q2 24 | $1.4M | $-5.6M | ||
| Q1 24 | $168.2K | $12.8M |
| Q4 25 | 20.3% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 4.4% | — | ||
| Q1 25 | 10.7% | — | ||
| Q4 24 | 20.0% | — | ||
| Q3 24 | 21.7% | — | ||
| Q2 24 | 24.6% | — | ||
| Q1 24 | 18.6% | — |
| Q4 25 | 6.4% | -18.5% | ||
| Q3 25 | 9.1% | -1.5% | ||
| Q2 25 | -13.1% | -28.3% | ||
| Q1 25 | -7.7% | -9.2% | ||
| Q4 24 | 9.5% | -11.8% | ||
| Q3 24 | 7.6% | -74.6% | ||
| Q2 24 | 11.2% | -69.4% | ||
| Q1 24 | 4.4% | 54.2% |
| Q4 25 | 3.6% | -34.7% | ||
| Q3 25 | 5.8% | -5.1% | ||
| Q2 25 | -8.7% | -32.7% | ||
| Q1 25 | -8.6% | -13.3% | ||
| Q4 24 | 4.5% | -25.0% | ||
| Q3 24 | 3.9% | -82.2% | ||
| Q2 24 | 6.8% | -76.5% | ||
| Q1 24 | 0.9% | 50.6% |
| Q4 25 | $0.04 | $-0.17 | ||
| Q3 25 | $0.09 | $-0.02 | ||
| Q2 25 | $-0.10 | $-0.11 | ||
| Q1 25 | $-0.10 | $-0.04 | ||
| Q4 24 | $0.08 | $-0.02 | ||
| Q3 24 | $0.06 | $-0.21 | ||
| Q2 24 | $0.11 | $-0.20 | ||
| Q1 24 | $0.01 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $36.8M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $25.8M | $35.5M |
| Total Assets | $75.2M | $70.6M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $36.8M | ||
| Q3 25 | — | $21.9M | ||
| Q2 25 | — | $18.7M | ||
| Q1 25 | — | $22.7M | ||
| Q4 24 | — | $26.6M | ||
| Q3 24 | — | $40.3M | ||
| Q2 24 | — | $43.1M | ||
| Q1 24 | — | $51.2M |
| Q4 25 | $0 | — | ||
| Q3 25 | — | $19.4M | ||
| Q2 25 | — | $19.4M | ||
| Q1 25 | — | $19.4M | ||
| Q4 24 | $26.5K | $19.3M | ||
| Q3 24 | — | $32.1M | ||
| Q2 24 | — | $31.8M | ||
| Q1 24 | — | $31.3M |
| Q4 25 | $25.8M | $35.5M | ||
| Q3 25 | $25.0M | $-4.5M | ||
| Q2 25 | $23.8M | $-7.5M | ||
| Q1 25 | $24.9M | $-5.9M | ||
| Q4 24 | $25.9M | $-5.9M | ||
| Q3 24 | $24.9M | $-5.2M | ||
| Q2 24 | $24.1M | $-1.4M | ||
| Q1 24 | $22.5M | $3.0M |
| Q4 25 | $75.2M | $70.6M | ||
| Q3 25 | $74.1M | $49.3M | ||
| Q2 25 | $72.3M | $44.9M | ||
| Q1 25 | $65.4M | $46.4M | ||
| Q4 24 | $68.0M | $44.9M | ||
| Q3 24 | $68.9M | $58.9M | ||
| Q2 24 | $70.2M | $63.2M | ||
| Q1 24 | $70.8M | $69.2M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.1M | $-6.0M |
| Free Cash FlowOCF − Capex | $-2.1M | — |
| FCF MarginFCF / Revenue | -10.8% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | -3.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.1M | $-6.0M | ||
| Q3 25 | $212.1K | $1.5M | ||
| Q2 25 | $-596.3K | $-3.7M | ||
| Q1 25 | $-2.7M | $-4.3M | ||
| Q4 24 | $4.4M | $-1.5M | ||
| Q3 24 | $715.1K | $-2.2M | ||
| Q2 24 | $-591.7K | $-8.4M | ||
| Q1 24 | $-960.5K | $39.0M |
| Q4 25 | $-2.1M | — | ||
| Q3 25 | $211.1K | — | ||
| Q2 25 | $-599.8K | — | ||
| Q1 25 | $-2.8M | — | ||
| Q4 24 | $4.3M | — | ||
| Q3 24 | $586.9K | — | ||
| Q2 24 | $-746.9K | — | ||
| Q1 24 | $-1.0M | — |
| Q4 25 | -10.8% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | -4.0% | — | ||
| Q1 25 | -18.1% | — | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 3.0% | — | ||
| Q2 24 | -3.6% | — | ||
| Q1 24 | -5.3% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | -3.03× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.42× | — | ||
| Q1 24 | -5.71× | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVU
| Government Subcontracts | $16.4M | 85% |
| Commercial Contracts | $2.3M | 12% |
| Prime Government Contracts | $725.8K | 4% |
FENC
Segment breakdown not available.
